INCIDENCE OF A SUBCLINICAL FASCIOLIASIS ON ANTIPYRINE CLEARANCE AND METABOLITE EXCRETION IN SHEEP

被引:38
作者
TUFENKJI, AE [1 ]
ALVINERIE, M [1 ]
PINEAU, T [1 ]
BOULARD, C [1 ]
GALTIER, P [1 ]
机构
[1] INRA,PHARMACOL TOXICOL LAB,180 CHEM DE TOURNEFEUILLE,F-31300 TOULOUSE,FRANCE
关键词
D O I
10.3109/00498258809041671
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:357 / 364
页数:8
相关论文
共 24 条
[1]   BIOCHEMICAL INDICATORS OF LIVER-INJURY IN CALVES WITH EXPERIMENTAL FASCIOLIASIS [J].
ANDERSON, PH ;
BERRETT, S ;
BRUSH, PJ ;
HEBERT, CN ;
PARFITT, JW ;
PATTERSON, DSP .
VETERINARY RECORD, 1977, 100 (03) :43-45
[2]  
BOULARD C, 1985, ANN RECH VET, V16, P363
[3]   SCALING OF ANTIPYRINE INTRINSIC CLEARANCE OF UNBOUND DRUG IN 15 MAMMALIAN-SPECIES [J].
BOXENBAUM, H ;
FERTIG, JB .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1984, 9 (02) :177-183
[4]   INTERSPECIES PHARMACOKINETIC SCALING AND THE EVOLUTIONARY-COMPARATIVE PARADIGM [J].
BOXENBAUM, H .
DRUG METABOLISM REVIEWS, 1984, 15 (5-6) :1071-1121
[6]   STUDIES ON RAT-LIVER CYTOCHROME-P-450S INVOLVED IN THE METABOLISM OF ANTIPYRINE - PHENOBARBITAL-METHYLCHOLANTHRENE-INDUCIBLE AND 3-METHYLCHOLANTHRENE-INDUCIBLE ISOZYMES POSSESSING 4-HYDROXYLASE ACTIVITY [J].
BUPPODOM, P ;
KOGA, N ;
YAMADA, H ;
YOSHIMURA, H .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (08) :1404-1406
[7]   ASSAY OF ANTIPYRINE AND ITS PRIMARY METABOLITES IN PLASMA, SALIVA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND SOME PRELIMINARY-RESULTS IN MAN [J].
DANHOF, M ;
GROOTVANDERVIS, ED ;
BREIMER, DD .
PHARMACOLOGY, 1979, 18 (04) :210-223
[8]   STUDIES ON THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN RATS - INFLUENCE OF PHENOBARBITAL AND 3-METHYLCHOLANTHRENE TREATMENT [J].
DANHOF, M ;
KROM, DP ;
BREIMER, DD .
XENOBIOTICA, 1979, 9 (11) :695-702
[9]   DRUG-METABOLISM IN LIVER-DISEASE - ACTIVITY OF HEPATIC MICROSOMAL METABOLIZING ENZYMES [J].
FARRELL, GC ;
COOKSLEY, WGE ;
POWELL, LW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :483-492
[10]  
GALTIER P, 1986, DRUG METAB DISPOS, V14, P137